Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
The Effect of Paternal SSRI Exposure during the Periconception Period on the Fetus
EF 2021-22
Résumé
Depression is a common mental illness that affects many parents. Consequently, selective serotonin reuptake inhibitors (SSRIs) are prescribed to 60% of fathers with depression during the preconception period. Many studies in both humans and animals have shown that maternal SSRI use results in an increased risk of the fetus developing various metabolic and psychiatric disorders. However, the effects of paternal exposure to SSRIs during the periconception period are not clear. The goal of this study is to test the hypothesis that paternal SSRI exposure will adversely affect pregnancy and fetal outcomes; an effect mediated via changes in the sperm epigenome. To test this hypothesis, male rats will be given fluoxetine (one of the most commonly used SSRIs for treatment of depression) or vehicle for 65 days prior to mating (encompasses full cycle of sperm production) with non-exposed females. The effect of SSRIs on the fetus will be assessed two ways: (1) a subset of dams at gestational day 15 will be sacrificed to assess fetal and placental growth, and (2) after the dams give birth, pregnancy success, birth weight, sex ratio, gestational length, live birth index, and litter size will be determined. As well, the effects of SSRIs on sperm will be assessed by sacrificing breeder males (from above) after mating to collect sperm. The sperm will be assessed for changes in sperm quality, modifications of the sperm epigenome, and upregulation of cellular stress markers, which will inform on the potential causes of the outcomes seen in the fetuses and pups. Ultimately, the results from this study will contribute to the dialogue surrounding paternal use of antidepressants during the preconception period.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466787
Name
Hamoodi Zaineb
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Effect of Paternal SSRI Exposure during the Periconception Period on the Fetus
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Fertility; Male Rat; Paternal Antidepressant Exposure; Selective Serotonin Reuptake Inhibitors; Sperm Epigenome; Sperm Quality
Abstract
Depression is a common mental illness that affects many parents. Consequently, selective serotonin reuptake inhibitors (SSRIs) are prescribed to 60% of fathers with depression during the preconception period. Many studies in both humans and animals have shown that maternal SSRI use results in an increased risk of the fetus developing various metabolic and psychiatric disorders. However, the effects of paternal exposure to SSRIs during the periconception period are not clear. The goal of this study is to test the hypothesis that paternal SSRI exposure will adversely affect pregnancy and fetal outcomes; an effect mediated via changes in the sperm epigenome. To test this hypothesis, male rats will be given fluoxetine (one of the most commonly used SSRIs for treatment of depression) or vehicle for 65 days prior to mating (encompasses full cycle of sperm production) with non-exposed females. The effect of SSRIs on the fetus will be assessed two ways: (1) a subset of dams at gestational day 15 will be sacrificed to assess fetal and placental growth, and (2) after the dams give birth, pregnancy success, birth weight, sex ratio, gestational length, live birth index, and litter size will be determined. As well, the effects of SSRIs on sperm will be assessed by sacrificing breeder males (from above) after mating to collect sperm. The sperm will be assessed for changes in sperm quality, modifications of the sperm epigenome, and upregulation of cellular stress markers, which will inform on the potential causes of the outcomes seen in the fetuses and pups. Ultimately, the results from this study will contribute to the dialogue surrounding paternal use of antidepressants during the preconception period.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hamoodi, Zaineb
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~